Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic financing round led by Shilpa Medicare Limited, a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufac…
Dx&Vx has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-development and license agreement valued at approximately USD 220 million with a U.S.-based biotech company for its mRNA-based cancer vaccine. Revenue sharing post-commercialization…
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, announces the completion of its acquisition of CRO company Micron,Inc. Following the acquisition, Micron will be integrated into Tigermed's global network as a key enti…
GSK plc announced it has entered into agreements with Hengrui Pharma to develop up to 12 innovative medicines, adding significant new growth opportunities to the company beyond 2031. The programmes were selected to complement GSK’s extensive Respiratory, Immunology & Inflammation (RI&I) and Oncology pipeline, …
Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, announced the signing of a Memorandum of Understanding (MOU) with the National Cancer Centre Singapore (NCCS). The partnership aims to support collaborative cell therapy research and clinical…
Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company (“NewCo”) focused on developing new therapies for autoimmune diseases that address significant unmet needs of patients. The newly formed company launches with five immunology assets in-licensed from BMS and a $3…
Simtra BioPharma Solutions, a leading global contract development and manufacturing (CDMO) specializing in injectable medicines, announced the purchase from Cook Group of a 65-acre property with more than 300,000 square feet of available space for expansion under-roof near its existing manufacturing facility in Bloomi…
Thermo Fisher Scientific Inc., the world leader in serving science, and the South African Medical Research Council (SAMRC), an entity of the Department of Health, together with South Africa’s Department of Science Innovation and Technology, have announced the official opening of a dedicated training facility for adva…
Biogen Inc. announced it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP). Since breaking ground in 1995, Biogen’s manufacturing in RTP has played a vital role in delivering the company’s pipeline and portfolio of innovative treatments …
Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, announced the acquisition of Novaestiq Corp. by Waldencast plc. Novaestiq, a joint venture between Croma-Pharma and Gore Range Capital, is the company behind the innovative Saypha ChIQ and Saypha MagIQ injectable hyaluronic acid gels, which a…
Page 34 of 40